John K Forrest
MD, FACC, FSCAI
Associate Professor of Medicine (Cardiovascular Medicine); Director of Interventional Cardiology, Cardiovascular Medicine; Director of Structural Heart Disease, Yale Medicine; Director, Structural Heart Disease Program, Cardiovascular Medicine
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Education & Training
- FellowshipYale University School of Medicine (2012)
- FellowshipYale University (2010)
- ResidencyYale-New Haven Hospital/Traditional Program (2008)
- InternshipYale-New Haven Hospital/Traditional Program (2006)
- MDYale University School of Medicine (2005)
- BSBowdoin College, History and Biochemistry
Activities
- TAVR in Women and BicuspidsVirtual Meeting 2021TAVR in Women and Bicuspids
- Primary Results of Evolut Low Risk Bicuspid StudyVirtual Conference 2020China Valve 2020
- Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and TricksOn-line Virtual Conference 2020Management of Coronary Disease Pre-and Post TAVR: Guidelines, Tips and Tricks
- Updates of Evolut Low Risk TrialVirtual Conference 2020China-US TAVR Summit Forum
- Critical Review of Evidence: TAVR in Low Risk Bicuspid PatientsVirtual Conference 2020Critical Review of Evidence: TAVR in Low Risk Bicuspid Patients
- Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid PatientsVirtual Conference 2020Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid Patients
- Blueprint for Bicuspid Treatment: TAVR Implant Strategies for Bicuspid PatientsVirtual Conference 2020Evolut Platform: Design Features, Outcomes, Implantation Tips and Tricks and Future Visions
- TAVR Optimization Strategies in Complex Anatomies: BicuspidVirtual Conference 2020Transcatheter Cardiovascular Therapeutics Annual Meeting 2020
- TAVR in Bicuspid Aortic ValvesSan Francisco, CA, United States 2019TAVR in Bicuspid Aortic Valves
- TAVR with High Risk for Coronary ObstructionSan Francisco, CA, United States 2019TAVR with High Risk for Coronary Obstruction
- TAVR Foundations for FellowsSan Francisco, CA, United States 2019TAVR Foundations for Fellows
- Latest Clinical Data in Bicuspid DiseaseChicago, IL, United States 2019Latest Clinical Data in Bicuspid Disease
- Valvular Heart Disease in 2019: A Field TransformedNew Orleans, LA, United States 2019Valvular Heart Disease in 2019: A Field Transformed
- Transcatheter Therapies: Potential RealizedNew Orleans, LA, United States 2019Transcatheter Therapies: Potential Realized
- New Technologies for Brain Protection During TAVRLas Vegas, NV, United States 2019New Technologies for Brain Protection During TAVR
- Con: Cerebral Embolic Protection is a Niche ConceptLas Vegas, NV, United States 2019Con: Cerebral Embolic Protection is a Niche Concept
- TAVR in Patients with a Bicuspid AnatomyNew York, NY, United States 2019TAVR in Patients with a Bicuspid Anatomy
- Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryWashington, DC, United States 2019Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
- Paravalvular Leak Post-TAVRSan Diego, CA, United States 2018Paravalvular Leak Post-TAVR
- Cerebral Embolic Protection During TAVRSan Diego, CA, United States 2018Cerebral Embolic Protection During TAVR
- Coronary Obstruction After TAVRSan Diego, CA, United States 2018Coronary Obstruction After TAVR
- The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve DiseaseSan Diego, CA, United States 2018The Road to Perdition: Severe Aortic Stenosis with Bicuspid Valve Disease
- TAVR Foundations for FellowsSan Diego, CA, United States 2018TAVR Foundations for Fellows
- Structural Heart Disease in 2018: Moving from TAVR to TMVR and MoreFarmington, CT, United States 2018Structural Heart Disease in 2018: Moving from TAVR to TMVR and More
- The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme CalcificationChicago, IL, United States 2018The Evolut PRO TAVR System: Confronting the Issues (Valve Sizing, New Pacemakers, Paravalvular Leak, and Extreme Calcification
- Debate: Cerebral Embolic Protection Should be Used in All (Most) CasesChicago, IL, United States 2018Debate: Cerebral Embolic Protection Should be Used in All (Most) Cases
- Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVRSan Diego, CA, United States 2018Challenging Structural Cases by the Experts: Predicting and Managing Coronary Obstruction during TAVR
- TAVR Update: Evolut Pro Clinical TrialsMiami, FL, United States 2018TAVR Update: Evolut Pro Clinical Trials
- 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT RegistrySan Diego, CA, United States 201830-Day Outcomes Following Transcatheter Aortic Valve Replacement with the Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT Registry
- TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and HospitalsDenver, CO, United States 2017TAVR Shift to Intermediate-Risk Patients: Practical Considerations for the Heart Team and Hospitals
- Evolut R TAVR - Technology Review Including Evolut 34mm and PRODenver, CO, United States 2017Evolut R TAVR - Technology Review Including Evolut 34mm and PRO
- Ask the Experts - How Do I Manage These Challenge Case Scenarios?Chicago, IL, United States 2017Ask the Experts - How Do I Manage These Challenge Case Scenarios?
- Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?Chicago, IL, United States 2017Optimizing Post-Dilation with Self-Expanding Valves - Does Balloon Choice Matter?
- Evolut R Snapshots I - The New Evolut R PRO SystemChicago, IL, United States 2017Evolut R Snapshots I - The New Evolut R PRO System
- Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and TricksNew Orleans, LA, United States 2017Procedural Perfection: Ideal TAVR Using the Evolut - All the Tips and Tricks
- How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good ResearchNew Orleans, LA, United States 2017How to Build a Successful Multidisciplinary Interventional Program: Balancing Pressures of Good Practice and Good Research
- Will SURTAVI Change my Practice: TAVI for Patients with Intermediate Risk?Paris, IDF, France 2017Will SURTAVI Change my Practice: TAVI for Patients with Intermediate Risk?
- Managing Complex Paravalvular LeaksAtlanta, GA, United States 2017Managing Complex Paravalvular Leaks
- Next Generation TAVI TechnologiesPrague, Prague, Czech Republic 2017Next Generation TAVI Technologies
- How to Mitigate the Risk of PVL post TAVRPrague, Prague, Czech Republic 2017How to Mitigate the Risk of PVL post TAVR
- Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial WrapDenver, CO, United States 2017Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial Wrap
- Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak ClosureParis, IDF, France 2017Transcatheter Mitral Valve-in-Ring with Concomitant Para-Ring Leak Closure
- Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro ValveParis, IDF, France 2017Recorded Case: Transcatheter Aortic Valve Replacement using Evolut Pro Valve
- 30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO SystemWashington, DC, United States 201730-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System
- All-Cause Mortality or Major Stroke by Valve Size After Self-Expanding Transcatheter Aortic Valve ReplacementSan Francisco, CA, United States 2016All-Cause Mortality or Major Stroke by Valve Size After Self-Expanding Transcatheter Aortic Valve Replacement
- Complex Cases Using a Self-Expanding TAVRAtlanta, GA, United States 2015Complex Cases Using a Self-Expanding TAVR
- Current Status of TAVR with the Self-Expanding CoreValve SystemAtlanta, GA, United States 2015Current Status of TAVR with the Self-Expanding CoreValve System
- Debate: Is TAVR or SAVR More Appropriate for All Comers: ProAtlanta, GA, United States 2015Debate: Is TAVR or SAVR More Appropriate for All Comers: Pro
- Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access TrialsSan Francisco, CA, United States 2015Transcatheter Aortic Valve Replacement in Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access Trials
- US Perspective: Optimizing Patient Selection and Imaging for TAVRWashington, DC, United States 2014US Perspective: Optimizing Patient Selection and Imaging for TAVR
- Transcatheter Aortic Valve Replacement 2014New London, CT, United States 2014Transcatheter Aortic Valve Replacement 2014
- Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market OpportunitiesLondon, England, United Kingdom 2014Innovation: New Frontier in Implantable Therapies: Clinical Need, Regulatory Challenges, and Market Opportunities
- A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe ThrombocytopeniaWashington, DC, United States 2014A True Hybrid Case: Off-Pump CABG and TAVR (Direct Aortic Approach using a 31mm CoreValve) in Patient with Left Main Disease, Bicuspid Aortic Valve Stenosis, and Severe Thrombocytopenia
- Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and OutcomesMedellín, Antioquia, Colombia 2013Treating Iliac, SFA, and Critical Limb Ischemia - Patient Screening, Prognosis, Treatment Options and Outcomes
- Focus of TAVR: Program, Patient Selections, and ComplicationsMedellín, Antioquia, Colombia 2013Focus of TAVR: Program, Patient Selections, and Complications
- Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating CorsairMiami, FL, United States 2012Recorded Case: Retrograde RCA CTO via RV Marginal: The Beating Corsair
- Complex Carotid StentingOrlando, FL, United States 2011Complex Carotid Stenting
- Device Choices for Percutaneous Aortic Paravalvular Leak ClosureVancouver, BC, Canada 2011Device Choices for Percutaneous Aortic Paravalvular Leak Closure
- Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trialParis, IDF, France 2011Evaluation of everolimus-eluting and paclitaxel eluting stents in patients with jailed side branches: two-year results from the SPIRIT IV trial
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| ACC Emerging Leadership Faculty | American College of Cardiology | 2019 |
| Yale Advanced Emerging Leadership Program | 2017 | |
| Fellow of the American College of Cardiology | 2016 | |
| Yale-New Haven Hospital Nurses Choice Award | 2016 | |
| Fellow of the Society for Cardiovascular Angiography and Interventions | 2015 | |
| The John P. Peters Prize | Yale School of Medicine | 2005 |
| NIH/NHLBI Student Research Grant Award | NIH/NHLBI | 2004 |
| Yale Club of New Haven Scholar | Yale Club of New Haven | 2001, 2002, 2003, 2004 |
| NIH Summer Research Fellowship Award | NIH | 2001 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Yale New Haven Health System | Aortic Stenosis Care Signature Pathway | 2022 |
| PROGRESS (TAVR for Moderate Aortic Stenosis and Cardiac Dysfunction) Trial | National/International Screening Committee | 2022 - Present |
| Structural Heart Advisory Board, Medtronic Inc | Board Member | 2022 - Present |
| Structrual Heart Data Evidence and Publications Committee, Medtronic | Chair | 2022 - Present |
| Yale University- Davenport College | Faculty Fellow at Davenport College Yale University | 2021 - Present |
| HVC Research Leadership Committee | Executive Committee Member | 2021 - Present |
| Yale New Haven Heath System | Lumedx Steering Committee | 2021 - Present |
| PROGRESS (TAVR for Moderate Aortic Stenosis and Cardiac Dysfunction) Trial | National/International Steering Committee | 2021 - Present |
| EVOLUT R Low Risk Randomized Clinical Trial | National/International Principal Investigator | 2021 - Present |
| New England Structural Heart Consortium | Annual Meeting | 2021 - Present |
| American College of Cardiology | STS/ACC TVT Mitral Risk Model Committee | 2021 - Present |
| Transcatheter Valve Therapies (TVT) | Annual Meeting | 2021 - Present |
| St. Thomas Day School | Chairman Board 2021-present | 2021 - Present |
| New England Structural Heart Consortium | Annual Meeting | 2021 - Present |
| New England Structural Heart Consortium | Annual Meeting | 2021 - Present |
| Journal of the American Medical Association (JAMA) | Reviewer | 2021 - Present |
| Journal of the Society for Cardiovascular Angiography (JSCAI) | Editorial Board Member | 2021 - Present |
| Journal of American College of Cardiology (JACC) | Guest Editor | 2021 - Present |
| Journal of American College of Cardiology (JACC) | Reviewer | 2020 - Present |
| JAMA Cardiology | Reviewer | 2020 - Present |
| St. Thomas Day School | Board Vice President | 2019 - 2021 |
| Society for Cardiovascular Angiography and Interventions (SCAI) | Annual Meeting | 2019 - 2020 |
| Transcatheter Cardiovascular Therapeutics (TCT) | Annual Meeting Abstract Review Committee | 2019 - Present |
| Society for Cardiovascular Angiography and Interventions | Annual Meeting | 2019 - Present |
| Transcatheter Cardiovascular Therapeutics | Abstract Selection Committee | 2019 - Present |
| Global Advisory Board, Medtronic Inc | Board Member | 2019 - Present |
| New England Structural Heart Annual Meeting | Co-Director | 2018 - Present |
| New England Structural Heart Consortium | Board of Directors | 2018 - Present |
| BICUSPID TAVR Clinical Trial | National Steering Committee | 2018 - 2020 |
| BICUSPID TAVR Clinical Trial | National Screening Committee | 2018 - 2020 |
| REFLECT 3 Clinical Trial | National Screening Committee | 2018 - 2020 |
| Yale University School of Medicine | Mission Statement Committee | 2018 - 2019 |
| New England Structural Heart Consortium | Founding Member | 2018 |
| BICUSPID TAVR Clinical Trial | National Principal Investigator | 2018 - Present |
| APOLLO Transcatheter Mitral Valve Replacement Clinical Trial | National Screening Committee | 2018 - Present |
| APOLLO Transcatheter Mitral Valve Replacement Clinical Trial | National Steering Committee | 2018 - Present |
| American College of Cardiology | STS/ACC TVT TAVR Risk Model Committee | 2018 - Present |
| American College of Cardiology | Abstract Selection Committee: Aortic Valve Disease | 2018 - Present |
| Transcatheter Cardiovascular Therapeutics (TCT) | Annual Meeting | 2018 - Present |
| Transcatheter Valve Therapies | Annual meeting (late breaking clinical trials, cases, innovation, moderated posters) reviewer | 2018 - Present |
| American College of Cardiology | Annual session Abstract Selection Committee Aorta Valve Disease | 2018 - Present |
| JACC Intervention | Reviewer | 2018 - Present |
| Yale University School of Medicine | Quality Committee | 2017 - 2019 |
| Yale New Haven Health System | Yale New Haven Health Systems Quality Committee | 2017 - 2019 |
| American College of Cardiology | TVT Dataset Update Working Group | 2017 - 2019 |
| Yale New Haven Hospital | HVC/ED Collaborative | 2017 - Present |
| TAVR UNLOAD Clinical Trial | National Screening Committee | 2017 - Present |
| EVOLUT R Low Risk Randomized TAVR Trial | National Steering Committee | 2017 - Present |
| Transcatheter Valve Therapies (TVT) | Annual Meeting | 2017 - Present |
| Transcatheter Valve Therapies (TVT) | Abstract Grader | 2017 - Present |
| American College of Cardiology | TVT Dataset Update | 2017 - Present |
| Transcatheter Cardiovascular Therapies | Annual meeting Session Chair | 2017 - Present |
| Transcatheter Valve Therapies | Annual meeting, Abstract Selection Committee | 2017 - Present |
| Transcatheter Valve Therapies | Annual meeting Session Chair | 2017 - Present |
| Aorta Journal | Editorial Board Member | 2017 - Present |
| US Advisory Board, Boston Scientific | Board Member | 2017 - Present |
| TAVR 2.0 Clinical Trial | Chair of National Steering Committee | 2016 - 2018 |
| TAVR 2.0 Clinical Trial | Chair of National Screening Committee | 2016 - 2017 |
| Yale University School of Medicine | Heart Care Team | 2016 - Present |
| TAVR 2.0 Clinical Trial | National Principal Investigator | 2016 - Present |
| Structural Heart Advisory Board, Edwards Lifesciences | Board Member | 2016 - Present |
| Yale-New Haven Hospital | Yale-New Haven Patient Experience Committee | 2015 - 2020 |
| St. Thomas Day School | Member Board of Governor's | 2015 - 2019 |
| FANTOM II Clinical Trial | Data Safety Monitoring Board (DSMB) | 2015 - 2018 |
| ABLATE Clinical Trial | Clinical Event Committee (CEC) | 2015 - 2016 |
| Yale University School of Medicine | Yale Medical Leadership Council | 2015 - Present |
| Yale New Haven Hospital | Yale medical Leadership Committee (MLC/JLC) | 2015 - Present |
| Medtronic | Medtronic Fundamentals of TAVR Fellows Course Co-Director | 2015 - Present |
| Edwards | Edwards TAVR Fellows Course Co-Director | 2015 - Present |
| Medtronic | Medtronic Advanced Users Evolut R Program Co-Chair | 2015 - Present |
| American Journal of Cardiology, Catheterization and Cardiovascular Interventions | Reviewer | 2015 - Present |
| Fundamentals of TAVR, Medtronic Inc | Co-Director | 2015 - Present |
| DEFLECT III Clinical Trial | Clinical Event Committee (CEC) | 2014 - 2015 |
| Transcatheter Valve Therapies (TVT) | Annual Meeting | 2014 - Present |
| DEFLECT II Clinical Trial | Clinical Event Committee (CEC) | 2013 - 2014 |
| Transcatheter Cardiovascular Therapeutics (TCT) | Annual Meeting | 2013 - Present |
| DEFLECT I Clinical Trial | Clinical Event Committee (CEC) | 2012 - 2013 |
Departments & Organizations
- Cardiovascular Medicine
- Internal Medicine
- Interventional Cardiology Program
- Structural Heart Disease Program
- Yale Medicine